A Phase Ib Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Cibisatamab in Combination With Atezolizumab After Pretreatment With Obinutuzumab in Participants With Previously Treated Metastatic Colorectal Adenocarcinoma
Clinical trial NCT03866239 · TERMINATED
Trial details
- NCT number
- NCT03866239
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-07
- Primary completion
- 2024-03-13
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.